ClearPoint Neuro (CLPT) Gross Margin (2011 - 2026)
ClearPoint Neuro recorded quarterly Gross Margin of 63.95% in Q1 2026, up 3.96% quarter-over-quarter from 61.52% in Q4 2025, and up 347.0% year-over-year from 14.31% in Q1 2025.
ClearPoint Neuro's Gross Margin history runs 15 years deep, the most recent figure standing at 63.95% for Q1 2026.
- In Q1 2026, Gross Margin rose 347.0% year-over-year to 63.95%; the TTM figure through Mar 2026 stood at 62.33% (up 113.0% YoY), while the FY2025 annual figure was 61.38%, up 46.0% from the prior year.
- Gross Margin came in at 63.95% for Q1 2026 at ClearPoint Neuro, up from 61.52% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 71.49% in Q3 2022 to a low of 52.54% in Q2 2023.
- A 5-year average of 61.39% and a median of 61.28% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin slumped 1469 bps in 2023 and soared 1094 bps in 2024, its largest moves.
- ClearPoint Neuro's Gross Margin stood at 65.06% in 2022, then retreated by 9 bps to 58.93% in 2023, then increased by 4 bps to 61.28% in 2024, then increased by 0 bps to 61.52% in 2025, then rose by 4 bps to 63.95% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 63.95%, 61.52%, and 63.2% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 63.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.95% |
| Dec 31, 2025 | 61.52% |
| Sep 30, 2025 | 63.20% |
| Jun 30, 2025 | 60.29% |
| Mar 31, 2025 | 60.48% |
| Dec 31, 2024 | 61.28% |
| Sep 30, 2024 | 59.68% |
| Jun 30, 2024 | 63.48% |
| Mar 31, 2024 | 59.24% |
| Dec 31, 2023 | 58.93% |
| Sep 30, 2023 | 56.80% |
| Jun 30, 2023 | 52.54% |
| Mar 31, 2023 | 58.94% |
| Dec 31, 2022 | 65.06% |
| Sep 30, 2022 | 71.49% |
| Jun 30, 2022 | 62.60% |
| Mar 31, 2022 | 64.22% |
| Dec 31, 2021 | 74.36% |
| Sep 30, 2021 | 66.48% |
| Jun 30, 2021 | 66.63% |
| Mar 31, 2021 | 64.86% |
| Dec 31, 2020 | 71.12% |
| Sep 30, 2020 | 74.34% |
| Jun 30, 2020 | 67.64% |
| Mar 31, 2020 | 70.09% |
| Dec 31, 2019 | 113.88% |
| Sep 30, 2019 | 63.68% |
| Jun 30, 2019 | 60.47% |
| Mar 31, 2019 | 64.15% |
| Dec 31, 2018 | 21.46% |
| Sep 30, 2018 | 69.39% |
| Jun 30, 2018 | 43.74% |
| Mar 31, 2018 | 40.73% |
| Sep 30, 2016 | 53.70% |
| Jun 30, 2016 | 51.15% |
| Mar 31, 2016 | 49.01% |
| Sep 30, 2015 | 53.66% |
| Jun 30, 2015 | -1,249.86% |
| Mar 31, 2015 | 60.53% |
| Dec 31, 2014 | -1,735.44% |
| Sep 30, 2014 | 46.31% |
| Jun 30, 2014 | 50.03% |
| Mar 31, 2014 | 57.37% |
| Dec 31, 2013 | 119.97% |
| Sep 30, 2013 | -1,187.96% |
| Jun 30, 2013 | 40.53% |
| Mar 31, 2013 | -47.02% |
| Dec 31, 2012 | 96.47% |
| Sep 30, 2012 | 88.22% |
| Jun 30, 2012 | -10.08% |
| Mar 31, 2012 | 6.15% |
| Dec 31, 2011 | 47.86% |
| Sep 30, 2011 | 73.33% |
| Jun 30, 2011 | 58.30% |
| Mar 31, 2011 | 89.31% |